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atent  ductus  arteriosus  (PDA)  is  one  of  the  most  frequent
ongenital  heart  defects  and  may  occur  as  an  isolated  lesion
r  in  association  with  others.  Its  incidence  varies  from  5%  to
0%  of  all  congenital  heart  disease  in  term  infants,1 increas-
ng  to  20%  to  60%  in  preterm  neonates.  This  is  attributable  to
he  lack  of  normal  closure  mechanisms  due  to  immaturity  in
he  premature  neonate.2 Most  patients  have  a  small  to  mod-
rate  PDA  causing  restrictive  flow  with  small  left-to-right
hunt,  presenting  as  symptom-free  or  with  few  symptoms.
he  natural  history  of  these  lesions  would  probably  be
neventful,  except  for  the  risk  of  infective  endocarditis.
oderate  to  large  PDA  will  cause  an  unrestrictive  flow,  with
otential  for  congestive  heart  failure  (HF)  and  pulmonary
ascular  disease.  The  rational  for  PDA  closure  is  to  prevent
ate  complications  such  as  canaliculitis,  HF  or  Eisenmenger
yndrome  in  late  age.  Exceptions  are  neonate  or  preterm
nfants  with  large  PDA  and  the  presence  of  severe  pulmonary
ypertension.
Since  the  first  successful  reports  of  surgical  treat-
ent  of  a  PDA,  by  Gross  and  Hubbard  in  1939,3 surgical
echnique----either  ligation  of  division----has  been  widely  used
or  large  and  symptomatic  PDA.  Although  it  has  been  shown
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ardiologists  have  always  tried  to  develop  a  transcatheter
ethod  to  close  PDA  and  other  anomalies.
The  first  report  on  non-surgical  closure  was  by  Portsmann
t  al.  in  1967.4 This  investigator  along  with  Rashkind  et  al.5
ioneered  the  development  of  several  PDA  closure  devices.
ue  to  their  efforts,  PDA  percutaneous  occlusion  became  an
ffective  and  safe  procedure,  and  is  nowadays  the  standard
ethod  for  PDA  closure.
After  these  initial  devices,  various  types  of  occlusion  sys-
ems  have  been  developed.  Gianturco,  Jackson  coils  (both
ree  and  detachable)  and  similar  devices  have  become  an
stablished  method  for  PDA  transcatheter  closure.6--9 Since
992,  coils  have  evolved  into  the  most  commonly  used
evices  for  small-sized  PDA  occlusion.  The  introduction  of
he  Amplatzer® duct  occluder  family  (ADO,  Abbott,  USA)  in
001,  changed  the  perspective  on  this  procedure,  because
f  increased  safety  characteristics,  like  retrievability,  repo-
itioning  and  also  the  possibility  to  close  defects  up  to
6  mm  in  diameter.  They  are  among  the  most  frequently
sed  occluders  for  large  and  moderate  PDA  occlusion.10--12
nother  recent  device  is  the  Nit-Occlud® (NOc,  pfm,  Ger-
any)  coil,  which  was  designed  specifically  for  PDA  closure.
his  coil  has  undergone  several  modifications  since  it  was
rst  developed,  with  the  latest  version  in  use  since  2001.13,14
rocedures  using  these  techniques  were  reported  to  be






















































































































afe  and  effective,  and  although  complications  occur,  crit-
cal  complications  are  rare.6--14 Device  embolization,  the
ost  feared  complication,  was  relatively  common  in  early
xperience  with  coils  but  became  rare  with  the  new  gen-
ration  of  devices.  Reported  occlusion  rates  vary  according
o  operator  experience,  and  post  procedure  period,  from
1%  immediately  after  the  procedure  to  95  to  100%  at  three
onths  of  follow  up.15--18 Nevertheless,  several  studies  have
emonstrated  that  intermediate  and  long-term  outcomes
f  percutaneous  PDA  occlusion  with  current  devices  are
xcellent.17--19
In  the  present  study,  Sarmento  et  al.20 present  the  results
ith  percutaneous  PDA  occlusion  from  a  single  center  for
welve  years  using  at  least  three  different  devices.  The
uthors  claim  to  report  one  of  the  largest  series  using  the
DA  NOc  devices,  which  adds  value  to  the  study.  In  their
eries,  the  immediate  procedural  occlusion  rate,  assessed
y  angiography,  was  high  (98.6%),  with  a  low  complication
ate  (1.8%),  and  a  single  case  of  embolization,  in  line  with
ther  reported  data.10,21 The  success  rate  was  associated
ith  vascular  accessibility,  morphology  of  the  ductus,  imag-
ng  modality,  and  adequate  selection  of  the  device.  The
tudy  adds  no  novelty  to  the  technique,  but  reports  on  an
mportant  case  experience  at  national  level.  However,  the
uthors  fail  to  explain  the  set  for  ‘‘adequate  selection  of
evice’’  and  the  criteria  for  performing  coil/device  clo-
ure.  Also,  regarding  the  results,  the  reported  occlusion  rate
efers  to  the  immediate  result,  assessed  by  aortography.  The
tudy  would  be  more  robust  if  the  authors  had  described  the
mmediate  or  24-hour  occlusion  rate  assessed  by  echocardio-
raphy,  which  would  enable  a  more  accurate  assessment  and
ong-term  outcomes,  as  we  would  expect  from  a  twelve-year
etrospective  study.  Despite  these  limitations,  the  study  is
f  value  and  it  gives  us  the  opportunity  to  discuss  issues
ermane  to  transcatheter  PDA  closure,  such  as  indications,
election  of  devices,  expected  results  and  future  perspec-
ives.
Percutaneous  PDA  occlusion  is  indicated  for  lesions  pre-
enting  with  suggestive  continuous  murmur,  confirmed  by
chocardiography.  Ductus  with  absence  of  these  typical
ndings,  so-called  ‘silent  ductus’,  should  not  be  occluded,
lthough  controversy  exists  with  some  authors  recommend-
ng  occlusion.22 Small  size  PDA  without  significant  left
entricle  overflow  should  be  treated  to  prevent  infective
ndocarditis.  Medium  and  large  size  defects,  which  present
ignificant  left-to-right  shunt,  are  treated  to  prevent  HF  and
ulmonary  vascular  occlusive  disease.
Adequate  patient  age  and  size  have  been  an  issue,  and
ndications  have  evolved  over  time  and  with  new  and  inno-
ative  PDA  occluding  devices.  Until  recently,  transcatheter
DA  closure  was  considered  the  procedure  of  choice  for
nfants  ≥6  kg  and  adults.  Although  an  exact  lower  weight
imit  has  not  been  set  for  a  safe  occlusion,  only  a  few  stud-
es  have  reported  results  in  neonates  and  infants  below
his  weight  threshold.23--25 Recently,  these  limits  have  been
xceeded  with  the  release  of  the  new  miniaturized  devices
dequate  for  premature  infants  under  1.5  kg.  There  is  an
ngoing  prospective  trial  to  compare  the  classic  surgical
pproach  to  percutaneous  PDA  occlusion  in  preterm  infants
ver  700  g  and  three  days  old,  using  the  Amplatzer® Piccolo
ccluder,  an  evolution  of  the  Amplatzer® additional  sizes





romising  early  and  mid-term  results,  need  to  be  confirmed
n  randomized  controlled  trials  before  they  can  become  a
tandard  of  care.
Patent  ductus  arteriosus  is  an  uncommon  anomaly  in
dults,  but  in  this  age  group  they  present  several  patho-
ogical  changes,  such  as  tortuosity,  calcification,  friability,
neurysm  formation  and  ductal  shortening.27 A  calcified
uct  is  more  fragile  and  difficult  to  cross  and  the  treat-
ent  option  was  surgery  with  cardiopulmonary  bypass,
o  overcome  complexity  and  complications.  However,  the
evelopment  of  new  occlusion  devices  that  can  be  deployed
n  the  arterial  side  have  enabled  percutaneous  occlusion  in
dult  patients.28,29 Treatment  selection  must,  however,  be
ade  on  an  individual  bases,  especially  in  heavily  calcified
nd  fragile  ducts.  Although  there  are  no  specific  guidelines
or  device  selection,  it  seems  logical  that  a  less  rigid  device
uch  as  ADO  II,  ADO  II  AS,  vascular  plugs  and  PDA  NOc  would
ause  less  shear  stress  on  these  fragile  walls.
Based  on  personal  experience,9,12 most  PDA  can  be
ccluded  using  a  percutaneous  approach,  keeping  in  mind
hat  the  selection  of  patients  and  devices  remains  the  major
actor  for  success  and  effectiveness,  so  it  is  important  to
ake  into  account  patient  characteristics,  PDA  shape,  size
nd  minimal  diameter.  Small  to  very-small  PDA  (<2.5  and
.5  mm  in  diameter  respectively,  with  continuous  murmur)
an  easily  be  occluded,  regardless  of  their  shape,  using
etachable  coils,  which  are  a  cheap  and  effective  choice.
evice  selection  for  conical  PDA  is  broader,  as  either  coils
r  ADO  devices  and  similar  can  be  used  depending  on  the
ize  and  minimum  diameter  of  the  PDA.  Although  there  is  no
xact  threshold,  the  latter  are  usually  used  to  occlude  PDA
ver  2.5  mm  in  diameter.  The  PDA  NOc  devices  are  recom-
ended,  in  most  studies,  to  occlude  small  to  moderate  PDA,
s  shown  by  the  authors  of  this  study  report.  ADO  devices  are
sed  with  greater  efficiency  in  ductus  of  a  larger  diameter
r  morphology  that  is  unfavorable  to  occlusion  with  coils.
Complete  PDA  occlusion  and  absence  of  complications
re  the  expected  results  of  percutaneous  PDA  occlusion.
esidual  shunting  is  more  common  with  coils  and  when
t  occurs,  it  has  to  be  treated  with  repeated  procedures,
s  it  may  lead  to  endocarditis  or  to  hemolysis.  Device
mbolization  is  rare  and  also  more  frequent  with  coils,
ith  an  occurrence  rate  <1%.  Device-induced  pulmonary
ranch  stenosis  or  aortic  coarctation  is  rarely  seen,  although
öppler  flow  acceleration  without  invasive  gradient  may
ccur,  it  might  resolve  spontaneously  with  growth.  Aortog-
aphy,  before  and  after  releasing  the  implanted  device,
s  the  method  selected  to  evaluate  immediate  result,  but
chocardiography  is  more  adequate  for  post-procedural
ssessment  and  quantification  of  incomplete  occlusion  and
ate  complications.  We  should  however  point  out,  that  when
sing  coils,  we  would  recommend  continuing  catheterization
ntil  complete  ductal  closure  is  documented  by  angiography,
ecause  of  increased  risk  of  embolization  and  hemolysis.
ascular  injury  from  the  delivery  system  is  another  feared
omplication,  especially  in  small  infants.  Nevertheless,  this
s  rarely  seen  with  experienced  operators,  also  taking  into
ccount  the  evolution  in  downsizing  delivery  sheaths  over
he  last  five  decades.
Finally,  transcatheter  PDA  closure  stands  as  the  standard
reatment  in  most  cases.  Coils  and  ADO  devices  or  similar  are


































29. Hong TE, Hellenbrand WE, Hijazi M. Trnascatheter closure
of patent ductus arteriosus in adults using the Amplatzer
duct occluder: initial resuls and follow-up. Indian Heart J.Revista  Portuguesa  de  Ca
pproach  is  feasible,  effective  and  safe  with  current  devices
nd  techniques  leading  to  excellent  outcomes.  Future  per-
pectives  foresee  the  evolution  of  techniques  to  address
ore  challenging  cases,  such  as  preterm  and  low  birth
eight  infants  and  complex  cases  in  adults,  with  high  occlu-
ion  rate  and  few  complications.  During  the  past  50  years,
e  have  witnessed  a  remarkable  evolution  in  techniques,
evices  and  delivery  systems,  so  we  can  only  anticipate  fur-
her  improvements  in  transcatheter  PDA  closure.
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